CORRADINI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.367
EU - Europa 7.192
AS - Asia 5.184
SA - Sud America 788
AF - Africa 127
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 3
Totale 22.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.195
SE - Svezia 2.236
SG - Singapore 1.567
CN - Cina 1.512
IT - Italia 1.507
GB - Regno Unito 1.292
BR - Brasile 603
DE - Germania 601
VN - Vietnam 595
HK - Hong Kong 537
FI - Finlandia 437
KR - Corea 244
FR - Francia 222
RU - Federazione Russa 194
UA - Ucraina 184
TR - Turchia 133
NL - Olanda 129
IN - India 121
ID - Indonesia 91
CA - Canada 84
AR - Argentina 74
BG - Bulgaria 62
MX - Messico 59
BD - Bangladesh 57
JP - Giappone 54
PL - Polonia 43
IQ - Iraq 40
LT - Lituania 39
IE - Irlanda 36
AU - Australia 34
BE - Belgio 34
PK - Pakistan 33
ZA - Sudafrica 31
AT - Austria 30
RO - Romania 27
AE - Emirati Arabi Uniti 26
ES - Italia 26
MA - Marocco 23
CL - Cile 22
CH - Svizzera 21
EC - Ecuador 21
UZ - Uzbekistan 19
MY - Malesia 18
VE - Venezuela 18
CO - Colombia 17
IL - Israele 16
SA - Arabia Saudita 15
DZ - Algeria 14
EG - Egitto 12
AZ - Azerbaigian 11
PY - Paraguay 11
TN - Tunisia 11
JO - Giordania 10
TW - Taiwan 10
KE - Kenya 9
KZ - Kazakistan 9
PT - Portogallo 9
BO - Bolivia 8
CR - Costa Rica 8
IR - Iran 8
NP - Nepal 7
OM - Oman 7
PH - Filippine 7
UY - Uruguay 7
AL - Albania 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
PE - Perù 6
RS - Serbia 6
BY - Bielorussia 5
HU - Ungheria 5
LB - Libano 5
LU - Lussemburgo 5
SI - Slovenia 5
TH - Thailandia 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GR - Grecia 4
KG - Kirghizistan 4
KH - Cambogia 4
KW - Kuwait 4
SY - Repubblica araba siriana 4
AO - Angola 3
HR - Croazia 3
LV - Lettonia 3
MK - Macedonia 3
NG - Nigeria 3
PA - Panama 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CD - Congo 2
CI - Costa d'Avorio 2
CY - Cipro 2
GA - Gabon 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
Totale 22.671
Salva come PNG Salva come JPEG
Città #
Stockholm 1.794
Santa Clara 1.008
Singapore 998
Ashburn 886
Fairfield 869
Southend 821
Hefei 543
Hong Kong 530
Woodbridge 489
Chandler 485
Houston 411
San Jose 369
Helsinki 368
London 318
Seattle 291
Cambridge 277
Jacksonville 260
Wilmington 256
Nyköping 255
Beijing 244
Dallas 244
Chicago 232
Seoul 230
Ann Arbor 209
Berlin 208
Dearborn 208
Modena 207
Council Bluffs 201
Ho Chi Minh City 200
Los Angeles 164
Hanoi 146
The Dalles 124
New York 108
San Diego 100
Milan 99
Bologna 90
Princeton 69
Lauterbourg 65
Munich 61
Sofia 61
Moscow 60
Frankfurt am Main 58
São Paulo 58
Rome 57
Shanghai 57
Jakarta 56
Izmir 54
Orem 51
Eugene 49
Parma 47
Buffalo 44
Redwood City 43
Salt Lake City 42
Amsterdam 36
Bremen 36
Tokyo 33
Yalova 33
Phoenix 32
Warsaw 32
Dublin 28
Brussels 27
Elk Grove Village 26
Nuremberg 26
Reggio Emilia 26
Toronto 25
Da Nang 24
Des Moines 24
Redondo Beach 24
Haiphong 23
Kent 23
Brooklyn 22
Chennai 22
Florence 22
Mexico City 22
San Francisco 20
Atlanta 19
Bari 19
Montreal 19
Paris 19
Rio de Janeiro 19
Tampa 19
Borzano 18
Hải Dương 17
Turku 17
Baghdad 16
Formigine 16
Hemrik 16
Nanjing 16
Rimini 16
Vienna 16
Brisbane 15
Guangzhou 15
Lappeenranta 15
Columbus 14
Dong Ket 14
Johannesburg 13
New Delhi 13
Sterling 13
Tashkent 13
Biên Hòa 12
Totale 16.159
Salva come PNG Salva come JPEG
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.810
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 473
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 458
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 420
Non-HFE Hepatic Iron Overload. 407
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 405
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 400
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 396
Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. 379
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 379
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 363
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 353
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 348
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 343
Subacute copper-deficiency myelopathy in a patient with occult celiac disease 340
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 338
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 330
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 322
Iron Regulation of Hepcidin Despite Attenuated Smad1,5,8 Signaling in Mice Without Transferrin Receptor 2 or Hfe. 319
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 316
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 314
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 311
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 311
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 310
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 293
Iron and steatohepatitis. 289
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 283
Disease progression and liver cancer in the ferroportin disease 282
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 281
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 280
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 276
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 258
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 258
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 258
Parametri predittivi e risposta sostenuta alla terapia antivirale combinata nell'epatite cronica attivva HCV correlata (ECA HCV) 255
Lack of enterocyte iron accumulation in the ferroportin disease 253
GLUCONEOGENIC SIGNALS DIRECTLY CONTROL IRON HOMEOSTASIS THROUGH HEPCIDIN 253
Capitolo 8 "Epatopatie da accumulo: malattia di Wilson ed emocromatosi", in Sezione I "Epatiti acute e croniche" 248
Fifty meanings of grey 247
The RGM/DRAGON family of BMP co-receptors. 244
Can Disruption of Basal Ganglia-Thalamocortical Circuit in Wilson Disease Be Associated with Juvenile Myoclonic Epilepsy Phenotype? 244
A Pair of Brothers with Aceruloplasminemia Due To A Novel Nonsense Mutation: Unusual Phenotype And Neurological Improvement After Iron-Chelation Therapy With Deferasirox 243
Clinical application of NGS in the diagnosis of iron overload disorders or hyperferritinemia of genetic origin 229
Hereditary hemochromatosis. 227
Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease 225
Molecular and clinical correlates in iron overload associated with mutations in ferroportin 223
CREB-H is a stress-regulator of hepcidin gene expression during early postnatal development 217
Hereditary Hemochromatosis 216
SEX HORMONES DIFFERENTLY REGULATE HEPCIDIN EXPRESSION AND IRON HOMEOSTASIS IN VIVO. 216
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study 216
Genetic iron overload disorders 211
A small molecule redistributes iron in ferroportin-deficient mice and patient-derived primary macrophages 210
EASL Clinical Practice Guidelines on haemochromatosis 198
Iron Metabolism in the Disorders of Heme Biosynthesis 193
Fortune favours the bold: finding the right route in the anemia's sea 192
Clinical risk scores for the early prediction of severe outcomes in patients hospitalized for COVID-19 190
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 186
null 186
Impact of natural neuromedin-B receptor variants on iron metabolism 186
Hereditary Haemochromatosis: the genes and the disease. 184
Labile plasma iron and echocardiographic parameters are associated to cardiac events in beta-thalassemic patients 181
Metodologia per l’adozione di linee guida cliniche in Medicina Interna. 181
Hyperferritinemia and diagnosis of type 1 Gaucher disease 180
Post COVID-19 irritable bowel syndrome 179
Idiopathic brain calcification in a patient with hereditary hemochromatosis 174
Assistenza sanitaria primaria. Vol. 2: La formazione medica per il suo sviluppo 166
Iron and the liver 164
Use of digital technologies to support cancer screening in community health promotion interventions: scoping review 161
STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo 160
Iron in Porphyrias: Friend or Foe? 157
A Population-based and Clinical Cohort Validation of the Novel Consensus Definition of Metabolic Hyperferritinemia 154
Fegato, pancreas e vie biliari. 154
Juvenile hemocromatosis associated with pathogenetic mutations of adult hemocromatosis genes 153
Consensus Statement on the definition and classification of metabolic hyperferritinaemia 149
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia (Nature Reviews Endocrinology, (2023), 19, 5, (299-310), 10.1038/s41574-023-00807-6) 143
Haemochromatosis 142
Assistenza sanitaria primaria. Aspetti culturali, metodi e strumenti per il suo sviluppo 138
Corrigendum to “EASL Clinical Practice Guidelines on haemochromatosis” [J Hepatol 2022 (77) 479–502](S0168827822002112)(10.1016/j.jhep.2022.03.033) 137
Erratum: Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene (Blood Cells, Molecules, and Diseases (2003) 31 (299-304) DOI: 10.1016/S1079-9796(03)00164-5) 127
Role and challenges to digital technologies in community health promotion programs in Italy during the COVID-19 pandemic: a multiple embedded case study protocol 126
Iron overload disorders 122
Developing an integrated care pathway to connect home-based palliative care and emergency departments: participatory action research on a quality improvement project 118
Prevalence and Characteristics of Metabolic Hyperferritinemia in a Population-Based Central-European Cohort 115
Hypoparathyroidism in adults with iron overload diseases (IOD): evidence of a subclinical phenotype 103
Reply to: “Ceruloplasmin variants might have different effects in different iron overload disorders” 102
Haemochromatosis in children: A national retrospective cohort promoted by the A.I.E.O.P. (Associazione Italiana Emato-Oncologia Pediatrica) study group 94
Haematological parameters in erythropoietic protoporphyria: A multi-national study 94
Prevalence of malnutrition and its impact on clinical outcomes in internal medicine wards: The SIMI-NUTRO study 88
SEX HORMONES DIFFERENTLY REGULATE HEPATIC HEPCIDIN EXPRESSION AND SYSTEMIC IRON HOMEOSTASIS IN VIVO 82
Psychological and Clinical Factors Mediate Post‐COVID‐19 Irritable Bowel Syndrome 74
Characterization of ferroportin disease and SLC40A1-related hemochromatosis – Results from the EASL non-HFE registry 47
Porphyrias: Pathophysiology and clinical management recommendations for hepatologists 42
Genome-wide association for sarcoidosis identifies novel risk loci and genetic heritability in African and European ancestries: a meta-analysis from the Finngen, Million Veteran Program, UK Biobank, and Biobank Japan datasets. 42
Lipidic nanomedicines enhance Hinokitiol activity on human primary macrophages from Ferroportin disease patients 26
Totale 22.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.262
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.262
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021478 0 0 0 0 0 0 0 0 0 160 137 181
2021/20221.503 90 127 179 58 82 65 111 104 196 107 216 168
2022/20231.571 153 165 110 137 197 208 44 177 186 39 90 65
2023/20241.179 59 68 128 118 152 83 96 159 35 83 101 97
2024/20254.019 165 48 100 255 757 593 222 223 459 193 501 503
2025/20269.503 560 426 816 817 883 677 1.051 485 2.833 955 0 0
Totale 22.870